Site US3304 — Wyomissing, Pennsylvania

Site US3304 is a clinical research site located in Wyomissing, Pennsylvania, United States 19610.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site US3304 has participated in 1 clinical trials.

Therapeutic areas: Arthritis, Rheumatoid.

Sponsors: Astellas Pharma Global Development, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Wyomissing

Browse all research sites in Pennsylvania · View every site in Wyomissing

• reading Hospital /ID# 223599
• Reading Hospital Study
• Reading Hospital/McGlinn Cancer Institute
• Clinical Research Center of Reading
• Research Site
• GSK Investigational Site
• Pfizer Investigational Site
• Berks Cardiologists, LTD
• Radiant Research
• Respiratory Specialists
• Clinical Research Center of Reading LLP
• Digestive Disease Associates

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US3304?

Site US3304 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US3304 conducted?

Site US3304 has 1 clinical trials on record. Their work covers Arthritis, Rheumatoid.

Is Site US3304 accredited by Crixeo Clinical Trials?

Site US3304 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US3304?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.